PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $52,000 | -68.7% | 5,004 | -73.7% | 0.02% | -54.5% |
| Q4 2019 | $166,000 | +403.0% | 19,009 | +511.4% | 0.03% | +266.7% |
| Q3 2019 | $33,000 | -86.9% | 3,109 | -84.3% | 0.01% | -87.7% |
| Q2 2019 | $252,000 | +950.0% | 19,845 | +3207.5% | 0.07% | +2333.3% |
| Q1 2019 | $24,000 | -46.7% | 600 | -71.9% | 0.00% | -80.0% |
| Q4 2018 | $45,000 | +400.0% | 2,139 | +969.5% | 0.02% | +650.0% |
| Q3 2018 | $9,000 | -93.6% | 200 | -92.0% | 0.00% | -93.8% |
| Q2 2018 | $141,000 | +2250.0% | 2,500 | +1150.0% | 0.03% | +3100.0% |
| Q4 2016 | $6,000 | -99.3% | 200 | -97.2% | 0.00% | -99.1% |
| Q2 2015 | $824,000 | +24.7% | 7,057 | +152.0% | 0.11% | -8.3% |
| Q1 2015 | $661,000 | +20.4% | 2,800 | -3.4% | 0.12% | -35.5% |
| Q4 2014 | $549,000 | – | 2,900 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |